Log In
Print this Print this

Promixin, colistimethate

  Manage Alerts
Collapse Summary General Information
Company Royal Philips Electronics N.V.
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationCystic fibrosis (CF)
Indication DetailsTreat patients with cystic fibrosis (CF) that have chest infections that are sensitive to promixin
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today